Tumorigenesis and tumor progression related gene expression profiles in colorectal cancer

Cancer Biomarkers

Volumn 13, Issue 4, 2013, Pages 269-279

  Huang, Ming Yii ^a,b   Chen, Hung Chang ^a   Yang, I Ping ^a,c   Tsai, Hsiang Lin ^a,d   Wang, Tsu Nai ^b   Juo, Suh Hang Hank ^b,c   Wang, Jaw Yuan ^a,c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d SHU ZEN COLLEGE OF MEDICINE AND MANAGEMENT   (Taiwan)

Author keywords

colorectal cancer; GeXP multiplexed assay; tumor progression; Tumorigenesis

Indexed keywords

BACULOVIRAL IAP REPEAT CONTAINING PROTEIN 5; BIOLOGICAL MARKER; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN E2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; MESSENGER RNA; MUCIN 1; MYC PROTEIN; PITRILYSIN; PROTEIN P53; PROTEIN S100B; RIBOSOMAL PROTEIN SA; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR SOX9; TRANSFERRIN RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERINEURAL INVASION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TAIWAN; TUMOR GROWTH; TUMOR INVASION; TUMOR VOLUME;

COLORECTAL CANCER; GEXP MULTIPLEXED ASSAY; TUMOR PROGRESSION; TUMORIGENESIS;

ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; TRANSCRIPTOME; TUMOR BURDEN;

EID: 84888612388     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130350     Document Type: Article

References (43)

1. S.J. Winawer, D. Schottenfeld and B.J. Flehinger, Colorectal cancer screening, J Natl Cancer Inst 83 (1991), 243-253.
2. M.P. Coleman, J. Esteve, P. Damiecki, A. Arslan and H. Renard, Trends in cancer incidence and mortality, IARC Sci Publ 121 (1993), 1-806.
3. R.W. Beart, G.D. Steele, H.R. Jr., Menck, J.S. Chmiel, K.E. Ocwieja and D.P. Winchester, Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the commission on cancer, J Am Coll Surg 181 (1995), 225-236.
4. P. Liang and A.B. Pardee, Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction, Science 257 (1992), 967-971.
5. E. Pennisi, A catalog of cancer genes at the click of a mouse, Science 276 (1997), 1023-1024.
6. G. Vasmatzis, M. Essand, U. Brinkmann, B. Lee and I. Pastan, Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis, Proc Natl Acad Sci U S A 95 (1998), 300-304.
7. V.E. Velculescu, L. Zhang, B. Vogelstein and K.W. Kinzler, Serial analysis of gene expression, Science 270 (1995), 484-487.
8. L. Zhang, W. Zhou, V.E. Velculescu, S.E. Kern, R.H. Hruban, S.R. Hamilton, B. Vogelstein and K.W. Kinzler, Gene expression profiles in normal and cancer cells, Science 276 (1997), 1268-1272.
9. S.E. Hufton, P.T. Moerkerk, R. Brandwijk, A.P. de Bruine, J.W. Arends and H.R. Hoogenboom, A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization, FEBS Lett 463 (1999), 77-82.
10. M.J. Luo and M.D. Lai, Identification of differentially expressed genes in normal mucosa, adenoma and adenocarcinoma of colon by SSH, World J Gastroenterol 7 (2001), 726-731.
11. W. Sun, K. Zhang, X. Zhang, W. Lei, T. Xiao, J. Ma, S. Guo, S. Shao, H. Zhang, Y. Liu, J. Yuan, Z. Hu, Y. Ma, X. Feng, S. Hu, J. Zhou, S. Cheng and Y. Gao, Identification of differentially expressed genes in human lung squamous cell carcinoma using suppression subtractive hybridization, Cancer Lett 212 (2004), 83-93.
12. M. Schena, D. Shalon, R.W. Davis and P.O. Brown, Quantitative monitoring of gene expression patterns with a complementary DNA microarray, Science 270 (1995), 467-470.
13. C. Shim, W. Zhang, C.H. Rhee and J.H. Lee, Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array, Clin Cancer Res 4 (1998), 3045-3050.
14. S. Backert, M. Gelos, U. Kobalz, M.L. Hanski, C. Bohm, B. Mann, N. Lovin, A. Gratchev, U. Mansmann, M.P. Moyer, E.O. Riecken and C. Hanski, Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array, Int J Cancer 82 (1999), 868-874.
15. D.A. Notterman, U. Alon, A.J. Sierk and A.J. Levine, Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays, Cancer Res 61 (2001), 3124-3130.
16. O. Kitahara, Y. Furukawa, T. Tanaka, C. Kihara, K. Ono, R. Yanagawa, M.E. Nita, T. Takagi, Y. Nakamura and T. Tsunoda, Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia, Cancer Res 61 (2001), 3544-3549.
17. F. Piard, C. Chapusot, A. Ecarnot-Laubriet, T. Ponnelle and L. Martin, Molecular markers of heterogeneity in colorectal cancers and adenomas, Eur J Cancer Prev 11 (2002), 85-97.
18. U. Alon, N. Barkai, D.A. Notterman, K. Gish, S. Ybarra, D. Mack and A.J. Levine, Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays, Proc Natl Acad Sci U S A 96 (1999), 6745-6750.
19. P. Hegde, R. Qi, R. Gaspard, K. Abernathy, S. Dharap, J. Earle-Hughes, C. Gay, N.U. Nwokekeh, T. Chen, A.I. Saeed, V. Sharov, N.H. Lee, T.J. Yeatman and J. Quackenbush, Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray, Cancer Res 61 (2001), 7792-7797.
20. K. Birkenkamp-Demtroder, L.L. Christensen, S.H. Olesen, C.M. Frederiksen, P. Laiho, L.A. Aaltonen, S. Laurberg, F.B. Sorensen, R. Hagemann and O.R. TF, Gene expression in colorectal cancer, Cancer Res 62 (2002), 4352-4363.
21. T.T. Zou, F.M. Selaru, Y. Xu, V. Shustova, J. Yin, Y. Mori, D. Shibata, F. Sato, S. Wang, A. Olaru, E. Deacu, T.C. Liu, J.M. Abraham and S.J. Meltzer, Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon, Oncogene 21 (2002), 4855-4862.
22. C.M. Frederiksen, S. Knudsen, S. Laurberg and T.F. Orntoft, Classification of Dukes B and C colorectal cancers using expression arrays, J Cancer Res Clin Oncol 129 (2003), 263-271.
23. N.S. Williams, R.B. Gaynor, S. Scoggin, U. Verma, T. Gokaslan, C. Simmang, J. Fleming, D. Tavana, E. Frenkel and C. Becerra, Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference, Clin Cancer Res 9 (2003), 931-946.
24. F. Bertucci, S. Salas, S. Eysteries, V. Nasser, P. Finetti, C. Ginestier, E. Charafe-Jauffret, B. Loriod, L. Bachelart, J. Montfort, G. Victorero, F. Viret, V. Ollendorff, V. Fert, M. Giovaninni, J.R. Delpero, C. Nguyen, P. Viens, G. Monges, D. Birnbaum and R. Houlgatte, Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters, Oncogene 23 (2004), 1377-1391.
25. B. Lu, Y. Fang, J. Xu, L. Wang, F. Xu, E. Xu, Q. Huang and M. Lai, Analysis of SOX9 expression in colorectal cancer, Am J Clin Pathol 130 (2008), 897-904.
26. L. Wang, X.X. Cao, Q. Chen, T.F. Zhu, H.G. Zhu and L. Zheng, DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation, Cancer Sci 100 (2009), 1801-1808.
27. J.E. Ying, L.S. Teng, G. Zhang and W.X. Lv, Relationship between the protein expression of P53, c-erbB-2, vascular endothelial growth factor and CD44 and the survival rates of stage IIC colorectal cancer patients without radiochemotherapy after radical resection, Zhonghua Wei Chang Wai Ke Za Zhi 12 (2009), 395-398.
28. A.B. Kunnumakkara, P. Diagaradjane, P. Anand, K.B. Harikumar, A. Deorukhkar, J. Gelovani, S. Guha, S. Krishnan and B.B. Aggarwal, Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model, Int J Cancer 125 (2009), 2187-2197.
29. M. Sheffer, M.D. Bacolod, O. Zuk, S.F. Giardina, H. Pincas, F. Barany, P.B. Paty,W.L. Gerald, D.A. Notterman and E. Domany, Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer, Proc Natl Acad Sci U S A 106 (2009), 7131-7136.
30. N. Stanilov, L. Miteva, N. Mintchev and S. Stanilova, High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma, Int J Colorectal Dis 24 (2009), 151-157.
31. C.C. Hwang, H.T. Chai, H.W. Chen, H.L. Tsai, C.Y. Lu, F.J. Yu, M.Y. Huang and J.Y. Wang, S100B protein expressions as an independent predictor of early relapse in UICC stages II and III colon cancer patients after curative resection, Ann Surg Oncol 18 (2011), 139-145.
32. A.J. Rai, R.M. Kamath, W. Gerald and M. Fleisher, Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed geneexpression profiling, Anal Bioanal Chem 393 (2009), 1505-1511.
33. A.J. Farquharson, R.J. Steele, F.A. Carey and J.E. Drew, Novel multiplex method to assess insulin, leptin and adiponectin regulation of inflammatory cytokines associated with colon cancer, Molecular Biology Reports 39 (2012), 5727-5736.
34. P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal Biochem 162 (1987), 156-159.
35. J.E. Drew, C.D. Mayer, A.J. Farquharson, P. Young and L.N. Barrera, Custom design of a GeXP multiplexed assay used to assess expression profiles of inflammatory gene targets in normal colon, polyp, and tumor tissue, The Journal of Molecular Diagnostics: JMD 13 (2011), 233-242.
36. Q.L. Liang, X.D. Chen, S.M. Wang, J.W. Li, B. Huang, Y.Y. Xu and X.S. Chen, Expression of vascular endothelial growth factor and metastin in colorectal carcinoma, Nan Fang Yi Ke Da Xue Xue Bao 27 (2007), 1584-1587.
37. Z.Q. Zhao, S. Yang and H.S. Lu, Expression of midkine and vascular endothelial growth factor in gastric survival, Mol Med Report 5 (2012), 415-419.
38. S. Wilson, T. Taskila, T. Ismail, D.D. Stocken, A. Martin, V. Redman, M. Wakelam, I. Perry and R. Hobbs, Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme, BMC Cancer 9 (2009), 36.
39. M.A. Lee, G.S. Park, H.J. Lee, J.H. Jung, J.H. Kang, Y.S. Hong, K.S. Lee, D.G. Kim and S.N. Kim, Survivin expression and its clinical significance in pancreatic cancer, BMC Cancer 5 (2005), 127.
40. X.L. Qin, H.Z. Xue, Z.R. Wang, H.S. Liu, H.B. Zhou and W. Ma, Expression of survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis, Zhonghua Wai Ke Za Zhi 47 (2009), 1852-1856.
41. J.W. Huh, H.R. Kim and Y.J. Kim, Prognostic value of perineural invasion in patients with stage II colorectal cancer, Ann Surg Oncol 17 (2010), 2066-2072.
42. H.L. Tsai, K.S. Chu, Y.H. Huang, Y.C. Su, J.Y.Wu, C.H. Kuo, C.W. Chen and J.Y. Wang, Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection, J Surg Oncol 100 (2009), 736-743.
43. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. DAmico, J.P. Richie, E.S. Lander, M. Loda, P.W. Kantoff, T.R. Golub and W.R. Sellers, Gene expression correlates of clinical prostate cancer behavior, Cancer Cell 1 (2002), 203-209.